Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. MEDIFAST INC (MED - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.
MEDIFAST INC is one of 176 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #15 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for MED's full-year earnings has moved 23.29% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, MED has moved about 206.53% on a year-to-date basis. Meanwhile, stocks in the Consumer Staples group have lost about 6.73% on average. This shows that MEDIFAST INC is outperforming its peers so far this year.
Looking more specifically, MED belongs to the Food - Miscellaneous industry, which includes 42 individual stocks and currently sits at #212 in the Zacks Industry Rank. This group has lost an average of 5.02% so far this year, so MED is performing better in this area.
MED will likely be looking to continue its solid performance, so investors interested Consumer Staples stocks should continue to pay close attention to the company.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. MEDIFAST INC (MED - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.
MEDIFAST INC is one of 176 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #15 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for MED's full-year earnings has moved 23.29% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, MED has moved about 206.53% on a year-to-date basis. Meanwhile, stocks in the Consumer Staples group have lost about 6.73% on average. This shows that MEDIFAST INC is outperforming its peers so far this year.
Looking more specifically, MED belongs to the Food - Miscellaneous industry, which includes 42 individual stocks and currently sits at #212 in the Zacks Industry Rank. This group has lost an average of 5.02% so far this year, so MED is performing better in this area.
MED will likely be looking to continue its solid performance, so investors interested Consumer Staples stocks should continue to pay close attention to the company.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MED - FREE